Sino Biological Anno...
9th November 2023 Content supplied by: Sino Biological US Inc.
Respiratory Syncytial Virus (RSV) Antigens and Antibodies
Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract illness in children globally. Sino Biological has developed a comprehensive collection of RSV-related reagents for viral research (18 antigens, seven antibodies, 80+ ELISA Kits, and cDNAs) that cover RSV A and B from over five strains, which can support therapeutic antibody, vaccine, and immunodiagnostic assay development.
Featured Product: Validated RSV Pre-F Trimer Protein
The Fusion (F) protein presents as a trimer on the surface of the RSV virion and plays a key role in virus invasion. Obtaining stable pre-fusion (Pre-F) proteins is crucial for RSV vaccine development. Sino Biological has developed a stable pre-fusion protein with a 90% trimerization ratio validated by SEC-MALS, which can support the development of RSV vaccines.
- Stable Prefusion Conformation Verified by Conformation-specific Antibodies
- Trimer purity ≥90%, validated by SEC-MALS
- High lot-to-lot consistency
- Stable CHO expression, gram-scale supply in a single batch
Learn more or ask for details using the green button below.
Date Published: 9th November 2023
Source article link: View
Sino Biological Announces the Opening